Coronary artery bifurcation narrowing treated by Axxess stent implantation: The CARINAX registry
| Autor: | Massimo Mancone, Simone Calcagno, Rocco Stio, Luigi Lucisano, Mauro Pennacchi, Nicola Labalestra, Gennaro Sardella, Amelia Focaccio, Carlo Briguori, Gabriella Visconti, Michael Donahue, Vito Di Palma, Giuseppe Signoriello |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
medicine.medical_specialty
business.industry medicine.medical_treatment Percutaneous coronary intervention Stent General Medicine 030204 cardiovascular system & hematology Confidence interval Surgery Lesion 03 medical and health sciences 0302 clinical medicine Main vessel medicine.anatomical_structure Occlusion medicine Stent implantation Radiology Nuclear Medicine and imaging 030212 general & internal medicine medicine.symptom Cardiology and Cardiovascular Medicine business Artery |
| Zdroj: | Catheterization and Cardiovascular Interventions. 89:E112-E123 |
| ISSN: | 1522-1946 |
| Popis: | OBJECTIVES To compare the safety and efficacy of the Axxess™ biolimus-eluting stent with the second-generation drug-eluting stent (DES) in the treatment of bifurcation lesions. BACKGROUND The Axxess™ is a dedicated bifurcation stent, designed to cover the lesion at the carina level. METHODS Between April 2012 and August 2014, 165 patients with de novo bifurcation lesions were treated with the Axxess™ stent (Axxess group). A propensity-score matched group of 165 patients treated with DES in the same period was selected (Control group). The primary objectives were (1) the procedural complication rate, including side branch (SB) occlusion and trouble in SB access after main vessel stenting; and (2) the device, the angiographic, and the procedural success rate. RESULTS Procedural complications occurred in 1 patient (0.6%) in the Axxess group and in 20 patients (12%) in the Control group (OR = 0.03; 95% confidence interval 0.005-0.27; P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text